FDA Information
Nizatidine was first developed by Eli Lilly & Co., and was marketed in 1987. It is considered to be equipotent with ranitidine and differs by the substitution of a thiazole-ring in place of the furan-ring in ranitidine.
Nazitidine proved to be the last new histamine H2-receptor antagonists introduced prior to the advent of proton pump inhibitors.
Certain preparations of nizatadine are now available over the counter (under the brand name Axid AR®) in various countries including the United States. The prescription version is known by the brand name Axid®.
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?